Senate bill · 89R

SB 2378

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

Did not pass

Progress

13 days from first to latest action, across 4 recorded actions.

Filed
Mar 12
Referred to committee
Mar 25
Heard in committee
Stopped here
Reported from committee
Passed first chamber
Passed second chamber
Sent to governor
Became law

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Full history

Every action recorded by Texas Legislature Online.

Referred to Health & Human Services Health and Human Services
Mar 25, 2025 · Senate
Read first time
Mar 25, 2025 · Senate
Filed
Mar 12, 2025 · Senate
Received by the Secretary of the Senate
Mar 12, 2025 · Senate

Authors

Kelly HancockR

In committee

Health and Human Services
Senate
Referred Mar 25, 2025 · never reported

Topics

Alcoholism & Drug Abuse Crimes: Drugs Education: Higher: Institutions & Programs State Agencies, Boards & Commissions

Bill text

IntroducedHTML PDF

Bills on similar topics

Other legislation this session sharing the most index topics.

Bill	Author	Progress	Status	Last action
HB 4783Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.	Gary VanDeaverR	Became law	Became law	Jun 20, 2025Effective on 9/1/25
HB 1103Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.	Sheryl ColeD	Referred to committee	Did not pass	Mar 7, 2025Referred to Higher Education
SB 556Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.	Nathan JohnsonD	Referred to committee	Did not pass	Feb 3, 2025Referred to Education K-16
SB 2308Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.	Tan ParkerR	Became law	Became law	Jun 11, 2025Effective immediately
HB 3062Relating to fentanyl prevention and drug poisoning awareness education for students enrolled in public institutions of higher education.	Bobby GuerraD	Became law	Became law	Jun 20, 2025Effective immediately
HB 35Relating to a peer support network for first responders.	Senfronia ThompsonD	Became law	Became law	Jun 20, 2025Effective on 9/1/25